These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury. Wang J; Ye Q; Xu J; Benedek G; Zhang H; Yang Y; Liu H; Meza-Romero R; Vandenbark AA; Offner H; Gao Y Transl Stroke Res; 2017 Jun; 8(3):284-293. PubMed ID: 27988839 [TBL] [Abstract][Full Text] [Related]
13. A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS. Sinha S; Subramanian S; Proctor TM; Kaler LJ; Grafe M; Dahan R; Huan J; Vandenbark AA; Burrows GG; Offner H J Neurosci; 2007 Nov; 27(46):12531-9. PubMed ID: 18003831 [TBL] [Abstract][Full Text] [Related]
14. Splenic responses play an important role in remote ischemic preconditioning-mediated neuroprotection against stroke. Chen C; Jiang W; Liu Z; Li F; Yang J; Zhao Y; Ran Y; Meng Y; Ji X; Geng X; Du H; Hu X J Neuroinflammation; 2018 May; 15(1):167. PubMed ID: 29807548 [TBL] [Abstract][Full Text] [Related]
15. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. Hurn PD; Subramanian S; Parker SM; Afentoulis ME; Kaler LJ; Vandenbark AA; Offner H J Cereb Blood Flow Metab; 2007 Nov; 27(11):1798-805. PubMed ID: 17392692 [TBL] [Abstract][Full Text] [Related]
16. Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke. Zhu W; Libal NL; Casper A; Bodhankar S; Offner H; Alkayed NJ Transl Stroke Res; 2014 Oct; 5(5):612-7. PubMed ID: 24953050 [TBL] [Abstract][Full Text] [Related]
17. Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke. Chang L; Chen Y; Li J; Liu Z; Wang Z; Chen J; Cao W; Xu Y Brain Behav Immun; 2011 Feb; 25(2):260-9. PubMed ID: 20869431 [TBL] [Abstract][Full Text] [Related]
18. RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS. Sinha S; Miller LM; Subramanian S; Burrows GG; Vandenbark AA; Offner H PLoS One; 2011; 6(7):e21868. PubMed ID: 21750737 [TBL] [Abstract][Full Text] [Related]
19. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. Bettelli E; Baeten D; Jäger A; Sobel RA; Kuchroo VK J Clin Invest; 2006 Sep; 116(9):2393-402. PubMed ID: 16955141 [TBL] [Abstract][Full Text] [Related]
20. Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke. Zhu W; Casper A; Libal NL; Murphy SJ; Bodhankar S; Offner H; Alkayed NJ Transl Stroke Res; 2015 Feb; 6(1):60-8. PubMed ID: 25270354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]